High concordance of TMPRSS-ERG fusion between primary prostate cancer and its lymph node metastases

about

High concordance of TMPRSS-ERG fusion between primary prostate cancer and its lymph node metastases

Item

http://www.wikidata.org/entity/Q58573182

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в листопаді 2018

@uk

name

High concordance of TMPRSS-ERG ...... and its lymph node metastases

@en

High concordance of TMPRSS-ERG ...... and its lymph node metastases

@nl

type

Item

label

High concordance of TMPRSS-ERG ...... and its lymph node metastases

@en

High concordance of TMPRSS-ERG ...... and its lymph node metastases

@nl

prefLabel

High concordance of TMPRSS-ERG ...... and its lymph node metastases

@en

High concordance of TMPRSS-ERG ...... and its lymph node metastases

@nl

P1476

High concordance of TMPRSS-ERG ...... and its lymph node metastases

@en

P2093

Andrea Hinsch

http://www.w3.org/2001/XMLSchema#string

Christina Möller-Koop

http://www.w3.org/2001/XMLSchema#string

Claudia Hube-Magg

http://www.w3.org/2001/XMLSchema#string

Corinna Wittmer

http://www.w3.org/2001/XMLSchema#string

Dagmar Lang

http://www.w3.org/2001/XMLSchema#string

Frank Jacobsen

http://www.w3.org/2001/XMLSchema#string

Franziska Brandi

http://www.w3.org/2001/XMLSchema#string

Hans Heinzer

http://www.w3.org/2001/XMLSchema#string

Hartwig Huland

http://www.w3.org/2001/XMLSchema#string

Katharina Grupp

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

Lymph node positive prostate cancer: long-term survival data after radical prostatectomy.

Effect of Gleason scores of lymph node metastases on prognosis of patients with prostate cancer.

TMPRSS2-ERG expression predicts prostate cancer survival and associates with stromal biomarkers.

Antineoplastic Effects of siRNA against TMPRSS2-ERG Junction Oncogene in Prostate Cancer.

Heterogeneity of ERG expression in prostate cancer: a large section mapping study of entire prostatectomy specimens from 125 patients.

Knocking Down TMPRSS2-ERG Fusion Oncogene by siRNA Could be an Alternative Treatment to Flutamide

The relationship of TMPRSS2-ERG gene fusion between primary and metastatic prostate cancers.

Development of Peptidomimetic Inhibitors of the ERG Gene Fusion Product in Prostate Cancer.

P304

6238-6244

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2018.9417

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30333886

http://www.w3.org/2001/XMLSchema#string

P921

cancer research

P932

6176457

http://www.w3.org/2001/XMLSchema#string